A study of the feasibility and accuracy of pharmacokinetically guided etoposide dosing in children
1998

Guided Etoposide Dosing in Children

Sample size: 9 publication Evidence: moderate

Author Information

Author(s): SP Lowis, L Price, ADJ Pearson, DR Newell, M Cole

Primary Institution: Royal Victoria Infirmary, Newcastle upon Tyne, UK

Hypothesis

Can pharmacokinetically guided dosing of etoposide improve treatment accuracy in children?

Conclusion

Pharmacokinetically guided dosing of etoposide is feasible and can achieve target AUC values with high precision.

Supporting Evidence

  • Target AUC values were achieved with a mean error of 11%.
  • Pharmacokinetic parameters showed less interpatient variability than previously reported.
  • Adaptive dosing was successfully performed in all nine patients.

Takeaway

Doctors can adjust the amount of medicine given to kids based on how their bodies process it, making treatment more accurate.

Methodology

Nine pediatric patients received etoposide, with doses adjusted based on the day-1 AUC measured using a limited sampling model.

Potential Biases

Potential bias due to the small number of patients and the specific conditions of the study.

Limitations

The study involved a small sample size and may not be generalizable to all pediatric patients.

Participant Demographics

Six male and three female patients, aged between 2 and 18 years.

Statistical Information

P-Value

p<0.05

Statistical Significance

p<0.05

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication